Cart
sales@molnova.com
Lead citrate
CAS No. 512-26-5
Lead citrate( —— )
Catalog No. M37961 CAS No. 512-26-5
Lead citrate
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 22 | In Stock |
|
| 10MG | 38 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 128 | In Stock |
|
| 200MG | 168 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLead citrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLead citrate
-
DescriptionLead citrate
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number512-26-5
-
Formula Weight999.8
-
Molecular FormulaC12H10O14Pb3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Myosin Kinase Inhibi...
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.
-
(Rac)-EC5026
(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) with a Ki of 0.06 nM, useful for research on Parkinson's disease and dementia with Lewy Bodies (DLB) .
-
Omeprazole metabolit...
Omeprazole sulfone can inhibit proton pump.
